Propofol increases bone morphogenetic protein-7 and decreases oxidative stress in sepsis-induced acute kidney injury

Nephrology Dialysis Transplantation

Volumn 26, Issue 4, 2011, Pages 1162-1172

  Hsing, Chung Hsi ^a,b,c   Chou, Willy ^a,c   Wang, Jhi Joung ^a   Chen, Hung Wei ^a   Yeh, Ching Hua ^a,d  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^d CHANG JUNG CHRISTIAN UNIVERSITY   (Taiwan)

Author keywords

acute kidney injury; bone morphogenetic protein 7; oxidative stress; propofol; sepsis

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOGENIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROPOFOL; TUMOR NECROSIS FACTOR ALPHA;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; KIDNEY CELL; MALE; MESANGIUM CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEPSIS; SURVIVAL RATE; TREATMENT RESPONSE;

ACUTE KIDNEY INJURY; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BONE MORPHOGENETIC PROTEIN 7; CECUM; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; HYDROGEN PEROXIDE; HYPNOTICS AND SEDATIVES; LIGATION; LIPOPOLYSACCHARIDES; MALE; MESANGIAL CELLS; MICE; MICE, INBRED BALB C; NF-KAPPA B; NITRIC OXIDE; OXIDATIVE STRESS; PROPOFOL; RATS; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEPSIS; SUPEROXIDES; SURVIVAL RATE;

EID: 79953862220     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq572     Document Type: Article

References (45)

1. Chen RM, Chen TG, Chen TL et al. Anti-inflammatory and antiox-idative effects of propofol on lipopolysaccharide-activated macro-phages. Ann NY Acad Sci 2005; 1042: 262-271
2. Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med 2004; 351: 159-169
3. Victor VM, Rocha M, De la Fuente M. Immune cells: free radicals and antioxidants in sepsis. Int Immunopharmacol 2004; 4: 327-347 (Pubitemid 38375967)
4. Wang W, Jittikanont S, Falk SA et al. Interaction among nitric oxide, reactive oxygen species, and antioxidants during endotoxemia-related acute renal failure. Am J Physiol Renal Physiol 2003; 284: F532-F537 (Pubitemid 36227915)
5. Yu Z, Zhang W, Kone BC. Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB. Biochem J 2002; 367: 97-105 (Pubitemid 35176895)
6. Stout RD. Macrophage activation by T cells: cognate and non-cognate signals. Curr Opin Immunol 1993; 5: 398-403 (Pubitemid 23197452)
7. West MA, Seatter SC, Bellingham J et al. Mechanisms of repro-grammed macrophage endotoxin signal transduction after lipopoly-saccharide pretreatment. Surgery 1995; 118: 220-228
8. Zager RA, Johnson AC, Lund S et al. Levosimendan protects against experimental endotoxemic acute renal failure. Am J Physiol Renal Physiol 2006; 290: F1453-F1462 (Pubitemid 43830772)
9. Almeida WS, Maciel TT, Di Marco GS et al. Escherichia coli lipo-polysaccharide inhibits renin activity in human mesangial cells. Kidney Int 2006; 69: 974-980 (Pubitemid 43372171)
10. Ortiz-Arduan A, Danoff TM, Kalluri R et al. Regulation of Fas and Fas ligand expression in cultured murine renal cells and in the kidney during endotoxemia. Am J Physiol 1996; 271: F1193-F1201
11. Heemskerk AE, Huisman E, van Lambalgen AA et al. Renal function and oxygen consumption during bacteraemia and endotoxaemia in rats. Nephrol Dial Transplant 1997; 12: 1586-1594 (Pubitemid 27346282)
12. Kohan DE. Role of endothelin and tumour necrosis factor in the renal response to sepsis. Nephrol Dial Transplant 1994; 9Suppl 473-77
13. van Lambalgen AA, van Kraats AA, van den Bos GC et al. Renal function and metabolism during endotoxemia in rats: role of hypoper-fusion. Circ Shock 1991; 35: 164-173
14. Poynter ME, Daynes RA. Peroxisome proliferator-activated receptor alpha activation modulates cellular redox status, represses nuclear factor-kappaB signaling, and reduces inflammatory cytokine production in aging. J Biol Chem 1998; 273: 32833-32841 (Pubitemid 28557672)
15. Lee S, Kim W, Kang KP et al. Agonist of peroxisome proliferator-activated receptor-gamma, rosiglitazone, reduces renal injury and dysfunction in a murine sepsis model. Nephrol Dial Transplant 2005; 20: 1057-1065 (Pubitemid 40862093)
16. Klahr S, Morrissey J. Obstructive nephropathy and renal fibrosis: the role of bone morphogenic protein-7 and hepatocyte growth factor. Kidney Int Suppl 2003; S105-S112 (Pubitemid 37315516)
17. Vukicevic S, Basic V, Rogic D et al. Osteogenic protein-1 (bone mor-phogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat. J Clin Invest 1998; 102: 202-214 (Pubitemid 28323847)
18. Wang SN, Lapage J, Hirschberg R. Loss of tubular bone morpho-genetic protein-7 in diabetic nephropathy. J Am Soc Nephrol 2001; 12: 2392-2399 (Pubitemid 33021116)
19. Zeisberg M, Bottiglio C, Kumar N et al. Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models. Am J Physiol Renal Physiol 2003; 285: F1060-F1067 (Pubitemid 37421041)
20. Gould SE, Day M, Jones SS et al. BMP-7 regulates chemokine, cyto-kine, and hemodynamic gene expression in proximal tubule cells. Kidney Int 2002; 61: 51-60 (Pubitemid 34075130)
21. Chan WL, Leung JC, Chan LY et al. BMP-7 protects mesangial cells from injury by polymeric IgA. Kidney Int 2008; 74: 1026-1039
22. Yeh CH, Chang CK, Cheng MF et al. The antioxidative effect of bone morphogenetic protein-7 against high glucose-induced oxidative stress in mesangial cells. Biochem Biophys Res Commun 2009; 382: 292-297
23. Yeh CH, Chang CK, Cheng MF et al. Decrease of bone morpho-genetic protein-7 (BMP-7) and its type II receptor (BMP-RII) in kidney of type-1 like diabetic rats. Horm Metab Res 2009; 41: 605-611
24. Mitu G, Hirschberg R. Bone morphogenetic protein-7 (BMP7) in chronic kidney disease. Front Biosci 2008; 13: 4726-4739 (Pubitemid 351589193)
25. Green TR, Bennett SR, Nelson VM. Specificity and properties of propofol as an antioxidant free radical scavenger. Toxicol Appl Pharmacol 1994; 129: 163-169 (Pubitemid 24352634)
26. Murphy PG, Myers DS, Davies MJ et al. The antioxidant potential of propofol (2, 6-diisopropylphenol). Br J Anaesth 1992; 68: 613-618
27. Hsu BG, Yang FL, Lee RP et al. Effects of post-treatment with low-dose propofol on inflammatory responses to lipopolysaccharide-induced shock in conscious rats. Clin Exp Pharmacol Physiol 2005; 32: 24-29 (Pubitemid 40314465)
28. Marik PE. Propofol: an immunomodulating agent. Pharmacotherapy 2005; 25: 28S-33S (Pubitemid 40604876)
29. Song XM, Wang YL, Li JG et al. Effects of propofol on pro-inflammatory cytokines and nuclear factor kappaB during polymicrobial sepsis in rats. Mol Biol Rep 2009; 36: 2345-2351
30. Brasil LJ, San-Miguel B, Kretzmann NA et al. Halothane induces oxidative stress and NF-kappaB activation in rat liver: protective effect of propofol. Toxicology 2006; 227: 53-61 (Pubitemid 44402849)
31. Runzer TD, Ansley DM, Godin DVet al. Tissue antioxidant capacity during anesthesia: propofol enhances in vivo red cell and tissue anti-oxidant capacity in a rat model. Anesth Analg 2002; 94: 89-93 table of contents (Pubitemid 34038725)
32. Vanlersberghe C, Camu F. Propofol. Handb Exp Pharmacol 2008; 227-252
33. Novelli GP. Role of free radicals in septic shock. J Physiol Pharmacol 1997; 48: 517-527 (Pubitemid 28055584)
34. Vespasiano MC, Lewandoski JR, Zimmerman JJ. Longitudinal analysis of neutrophil superoxide anion generation in patients with septic shock. Crit Care Med 1993; 21: 666-672 (Pubitemid 23139543)
35. Wang W, Falk SA, Jittikanont S et al. Protective effect of renal de-nervation on normotensive endotoxemia-induced acute renal failure in mice. Am J Physiol Renal Physiol 2002; 283: F583-F587
36. Gepts E, Camu F, Cockshott ID et al. Disposition of propofol administered as constant rate intravenous infusions in humans. Anesth Analg 1987; 66: 1256-1263 (Pubitemid 18024603)
37. Knotek M, Esson M, Gengaro P et al. Desensitization of soluble gua-nylate cyclase in renal cortex during endotoxemia in mice. J Am Soc Nephrol 2000; 11: 2133-2137
38. Goode HF, Webster NR. Free radicals and antioxidants in sepsis. Crit Care Med 1993; 21: 1770-1776 (Pubitemid 23332098)
39. Carcamo JM, Pedraza A, Borquez-Ojeda O et al. Vitamin C suppresses TNF alpha-induced NF kappa B activation by inhibiting I kappa B alpha phosphorylation. Biochemistry 2002; 41: 12995-13002 (Pubitemid 35215783)
40. Krysztopik RJ, Matheson PJ, Spain DA et al. Lazaroid and pentox-ifylline suppress sepsis-induced increases in renal vascular resistance via altered arachidonic acid metabolism. J Surg Res 2000; 93: 75-81
41. Knotek M, Rogachev B, Wang W et al. Endotoxemic renal failure in mice: role of tumor necrosis factor independent of inducible nitric oxide synthase. Kidney Int 2001; 59: 2243-2249 (Pubitemid 32467617)
42. Baud L, Ardaillou R. Reactive oxygen species: production and role in the kidney. Am J Physiol Renal Physiol 1986; 251: F765-F776
43. Helder MN, Ozkaynak E, Sampath KT et al. Expression pattern of osteogenic protein-1 (bone morphogenetic protein-7) in human and mouse development. J Histochem Cytochem 1995; 43: 1035-1044
44. Li T, Surendran K, Zawaideh MA et al. Bone morphogenetic protein 7: a novel treatment for chronic renal and bone disease. Curr Opin Nephrol Hypertens 2004; 13: 417-422 (Pubitemid 38901621)
45. Yeh CH, Chang KC, Cheng KC et al. Role of bone morphogenetic proteins-7 (BMP-7) in the renal improvement effect of DangGui (Angelica sinensis) in type 1-diabetic rats. Evid Based Complement Alternat Med 2009; in press